Accessing Pharma Markets in Eastern Europe
News Mar 05, 2012
In this new market reality, pharma companies still need to find a way to
capture maximum business potential in these key regions.
In order to discuss major concerns and overcome challenges resulting from these tendencies throughout the region, Fleming Europe is organizing a brand new conference – Pharma Excellence in the CEE, CIS, SEE and Turkey. A number of top-level pharmaceutical experts have accepted the invitation to present their strategies to accelerate market access and to ensure maximum return on investment, in the beautiful city of Budapest, on 14 – 15 June 2012.
This 2-day conference will be structured into presentations and interactive panel discussions focused on topics such as – opportunities and challenges within diversified market environments, the importance of clinical and economic value in market access, major regulatory concerns, payers' roles in the entire product life-cycle, critical insight into the HTA processes in the region, successful pathways for product launch, closed loop marketing, strategies to increase SFE and many more.
Regional pharmaceutical experts from Eli Lilly, Novartis, Teva, Zentiva, Mylan, Pfizer, Sanofi, Merck, Roche, GSK, AstraZeneca, Abbott, etc. will participate in this unique conference to share their knowledge and experience with you.